⚠ US Customers Notice: Certain prescription medications, including Modafinil and Armodafinil, are classified as Schedule IV controlled substances under US federal law and are not available for purchase or shipment to the United States. Learn more
email[email protected] We do not ship to the USA *T&C bookmark Bookmark
email [email protected]
About Us |  Drug Policy |  Privacy Policy |  Contact Us bookmark Bookmark
wishlist0
user
login
shopping0
View Cart Checkout
Review Us on trust

Important US Policy Update

Controlled Substance Restriction

In compliance with the United States Controlled Substances Act (21 U.S.C. § 841), Remedy Counter does not sell or ship the following Schedule IV controlled substances to addresses within the United States:

  • Modafinil (Modalert, Modvigil, Vilafinil)
  • Armodafinil (Waklert, Artvigil)

These products are available for purchase by customers in jurisdictions where they are legally sold. US visitors will see restricted access on these product pages, and the United States is not available as a shipping destination for these items.

Remedy Counter is a licensed Indian pharmacy operating in full compliance with Indian pharmaceutical export regulations. For questions, contact us at [email protected].

De Minimis Exemption & Tariff Update

These policy changes are only applicable to orders placed from the United States of America.

Remedy Counter online pharmacy wants to inform all our customers that starting August 29, 2025, the U.S. government will be removing the de minimis exemption. The de minimis exemption currently allows packages under $800 to enter the country duty-free and tax-free.

According to the U.S. Customs policy under Executive Order 14324 Suspending Duty-Free De Minimis Treatment for All Countries:

  • The orders that arrive in the USA before August 29, 2025, will follow the previous de minimis exemption rule.
  • Orders that will arrive in the USA after August 29, 2025, will be subject to the new rule. These packages will be required to pay the new taxes.


What We Want You To Know

  • RemedyCounter is trying to follow the best practices to protect our customers' interests.
  • We will currently hold all the orders till September 15, 2025, at the Remedy Counter. (It is important to note that this is a tentative date, and we will update you if our team makes any further changes.)

Our Suggestion

  • Our U.S. customers should only try to order medicines after mid-September 2025 to avoid disruptions. We will keep you informed if we receive any input from our logistics partners.
  • Our team is working diligently with logistics partners and customs authorities to minimize disruptions and ensure your orders reach you as quickly as possible.

To learn more about the same, we suggest you check out the following publications-

Your trust means a lot to us. We are here for you in this healthcare journey.

With Care,
Remedycounter


Email : [email protected]

Important Note- We request all our customers to wait for reliable global news or official carriers such as USPS, UPS, and FedEx to confirm that shipments to the USA have resumed before paying for any order.

Website Information Disclaimer

Medical Disclaimer: This website is not intended to provide medical advice of any kind; all material is provided for educational purposes only after being vetted by qualified medical professionals.

Remedy Counter provides no medical advice, diagnosis, or treatment. All of the website's content, including cited clinical and scientific research data, is accessible solely for educational and informational purposes. Our team of professionals works tirelessly to ensure that all information on our website has been meticulously researched and is accessible to our readers. The data provided on Remedy Counter adheres to national and international guidelines for medical and clinical trials. Before taking any of the medications on our website, we advise everyone to consult with a doctor.

Regulatory Disclaimer: Products listed on this website are subject to the laws and regulations of the destination country. Certain products, including Modafinil and Armodafinil, are classified as Schedule IV controlled substances in the United States and are not available for sale or shipment to the U.S.

Remedy Counter is a licensed Indian pharmacy. We comply with all applicable Indian pharmaceutical export regulations. Customers are responsible for ensuring compliance with their local laws before placing an order.